Tag: Avia Dunn
Skadden, Latham & Watkins steer USD1.12bn biotech sale
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level